Stock Rating Upgrade In recent days the Value Trend Rating for W.R. Berkley Corp (NYSE: WRB) improved from C to B reflecting improving fundamentals and high Appreciation Potential. Recent Price Action W.R. Berkley Corp (NYSE: […]
Stock Rating Downgrade Reflecting eroding fundamentals and low Appreciation Potential, the Value Trend Rating for Energizer Holdings Inc (NYSE: ENR) weakened in recent days. ENR’s current Value Trend Rating is D and the prior Rating […]
Stock Rating Downgrade In recent days the Value Trend Rating for Astrazeneca PLC (NASDAQ: AZN) weakened from C to D reflecting eroding fundamentals and low Appreciation Potential. Recent Price Action Astrazeneca PLC (NASDAQ: AZN) stock […]
Stock Rating Downgrade In the last week the Value Trend Rating for Scully Royalty Ltd (NYSE: SRL) weakened from C to D reflecting eroding fundamentals and low Appreciation Potential. Recent Price Action Scully Royalty Ltd […]
Stock Rating Downgrade In recent days the Value Trend Rating for Astrazeneca PLC (NASDAQ: AZN) weakened from C to D reflecting eroding fundamentals and low Appreciation Potential. Recent Price Action Astrazeneca PLC (NASDAQ: AZN) stock […]
Stock Rating Downgrade Of late the Value Trend Rating for Adobe Inc (NASDAQ: ADBE) weakened from B to C reflecting eroding fundamentals and low Appreciation Potential. Recent Price Action Adobe Inc (NASDAQ: ADBE) stock closed […]
Stock Rating Downgrade During the last several trading days the Value Trend Rating for Flanigan’s Enterprises Inc. (NYSEAMERICAN: BDL) weakened from C to D reflecting eroding fundamentals and low Appreciation Potential. Recent Price Action Flanigan’s […]
Stock Rating Downgrade In recent days the Value Trend Rating for CGI Inc (NYSE: GIB) weakened from C to D reflecting eroding fundamentals and low Appreciation Potential. Recent Price Action On 1/12/24, CGI Inc (NYSE: […]
Stock Rating Downgrade In the last week the Value Trend Rating for Scully Royalty Ltd (NYSE: SRL) weakened from C to D reflecting eroding fundamentals and low Appreciation Potential. Recent Price Action Scully Royalty Ltd […]
Stock Rating Downgrade The Value Trend Rating for Fate Therapeutics Inc (NASDAQ: FATE) weakened recently from C to D reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included in our […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research